title: Association between preoperative statin therapy and postoperative infectious complications in patients undergoing cardiac surgery: a systematic review and meta-analysis.
abstract: Infectious complications of cardiac surgery are often severe and life threatening. Statins having both immunomodulatory and anti-inflammatory effects were intuitively thought to influence the development of postsurgical infections. We sought to systematically examine whether any association exists between statin use and risk of infectious complications in patients undergoing cardiac surgery. We searched Ovid MEDLINE, Ovid EMBASE, Thomson Scientific Web of Science, and Elsevier Scopus from inception through February 2011 for comparative studies examining the association between statin use and risk of postoperative infections in patients undergoing cardiac surgery. We contacted a study's author for missing information. We conducted a random-effects meta-analysis of individual studies' odds ratios (adjusted for potential confounders). We identified 6 cohort studies for inclusion, 3 of which were conducted in Canada and 3 of which were conducted in the United States. Four were single-center studies, and 2 were population based. Exposure ascertainment was based on a review of admission medication list or prescription databases. Infectious outcomes were heterogeneous and included surgical site infections within 30 days, serious infections (sepsis), or any other postoperative infection. Statin use in the preoperative period was associated with a trend toward reduction in the incidence of postoperative infections in patients who underwent cardiac surgery (odds ratio, 0.81 [95% confidence interval, 0.64-1.01]; [Formula: see text]; [Formula: see text]). Heterogeneity was explained by country effect. Studies performed in Canada showed weaker associations than studies performed in the United States. This difference could not be attributed to study quality alone. We did not find good evidence to support an association between statin use and postoperative infectious complications. However, the trend toward statistical significance for this association indicates that further investigation is warranted.
authors.affiliation: Department of Internal Medicine, King Fahad Medical City, Riyadh, Saudi Arabia. tleyjeh.imad@mayo.edu
authors.forename: Imad M
authors.initials: IM
authors.lastname: Tleyjeh
authors.forename: Faisal A
authors.initials: FA
authors.lastname: Alasmari
authors.forename: Aref A
authors.initials: AA
authors.lastname: Bin Abdulhak
authors.forename: Muhammad
authors.initials: M
authors.lastname: Riaz
authors.forename: Musa A
authors.initials: MA
authors.lastname: Garbati
authors.forename: Patricia J
authors.initials: PJ
authors.lastname: Erwin
authors.forename: Tarek
authors.initials: T
authors.lastname: Kashour
authors.forename: Mouaz H
authors.initials: MH
authors.lastname: Al-Mallah
authors.forename: Larry M
authors.initials: LM
authors.lastname: Baddour
mesh_terms: D002170:Canada; D002318:Cardiovascular Diseases / Q000601:surgery*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D011300:Preoperative Care; D013530:Surgical Wound Infection / Q000139:chemically induced*; D014481:United States
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors